Company Overview of Sirius Genomics Inc.
Sirius Genomics Inc., a biotechnology company, develops DNA-based companion diagnostics (CDx) and pharmacogenetic tests for acute medical conditions. Its products include CDx for activated protein C to treat severe sepsis, a systemic blood infection. The company was founded in 2001 and is based in Vancouver, Canada.
1125 Howe Street
Vancouver, BC V6Z 2K8
Founded in 2001
Key Executives for Sirius Genomics Inc.
Similar Private Companies By Industry
|Aegera Therapeutics, Inc.||Americas|
|Anandia Laboratories Inc.||Americas|
|Receptor Therapeutics Inc.||Americas|
|Neuropsychiatrie, Découverte & Innovation Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Sirius Genomics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.